A study from the Tokyo University of Science shows that targeting delta opioid receptors (DOP) in the brain’s PL-BLA pathway with the agonist KNT-127 can significantly reduce anxiety-like behavior in mice, paving the way for new anxiety disorder treatments. Credit: SciTechDaily.com Researchers from Tokyo University of Science uncover a novel mechanism of action involving specific neuronal circuits in the brain related to ‘anxiolytic’ or anxiety-reducing effects of therapeutic delta opioid receptor agonists. Credit: Yirui Sun
SciTechDaily
211 ngày
